Patents Assigned to Guard Therapeutics International AB
  • Alpha-1-microglobulin derived proteins and their use
    Patent number: 10981963
    Abstract: This invention relates to an alpha-1-microglobulin derived protein for medical use.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: April 20, 2021
    Assignee: Guard Therapeutics International AB
    Inventors: Lena Wester Rosenlöf, Anneli Edström Hägerwall, Bo Åkerström
  • Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy
    Patent number: 10960048
    Abstract: This invention relates to ?1-microglobulin (A1M) for use in the diagnosis or treatment of malignancies requiring radionuclide diagnostics (RD), radionuclide therapy (RNT) or radioimmunotherapy (RIT), respectively, wherein A1M is used as a co-treatment to RD, RNT or RIT.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: March 30, 2021
    Assignee: Guard Therapeutics International AB
    Inventors: Bo Åkerström, Sven-Erik Strand, Magnus Göran Gram, Amanda Thuy Tran